AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CLARITHROMYCIN 500.000 Mg ;

18 registrations across 1 African market— 18 active

Markets with CLARITHROMYCIN 500.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
CLARIOSTRONG
Extended Release Film Coated Tablets
🇪🇬EgyptThe National Company NAPCO PHARMA For Pharmaceuticals Industriesactive
CLARIKAN S.R.
Sustained Release Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
KLACID 500mg
Film Coated Tablets
🇪🇬EgyptAbbott Scientific Officeactive
Clarinotion
Sustained Release Film Coated Tablets
🇪🇬EgyptNotion Pharmaactive
Bedrevida
Extended Release Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Clarithromycin - EVA Pharma
Film Coated Tablets
🇪🇬EgyptEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
KLACID 500mg
Film Coated Tablets
🇪🇬EgyptAbbott Scientific Officeactive
Clarinotion
Sustained Release Film Coated Tablets
🇪🇬EgyptNotion Pharmaactive
CLARIOSTRONG
Extended Release Film Coated Tablets
🇪🇬EgyptThe National Company NAPCO PHARMA For Pharmaceuticals Industriesactive
Bedrevida
Extended Release Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
INFECTOCURE 500 mg
Film Coated Tablets
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Clarithromycin - EVA Pharma
Film Coated Tablets
🇪🇬EgyptEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
LARITHROCIN 500 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
CLARIKAN S.R.
Sustained Release Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
KLARIMIX
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive
INFECTOCURE 500 mg
Film Coated Tablets
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
LARITHROCIN 500 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
KLARIMIX
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive

CLARITHROMYCIN 500.000 Mg ; in Africa — Regulatory Overview

CLARITHROMYCIN 500.000 Mg ; is registered across 1 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.